List of Tables
Table 1. Global C Difficile Infection Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global C Difficile Infection Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global C Difficile Infection Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global C Difficile Infection Drug Sales (K MT) of Key Manufacturers (2020-2025)
Table 5. Global C Difficile Infection Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global C Difficile Infection Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global C Difficile Infection Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market C Difficile Infection Drug Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of C Difficile Infection Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of C Difficile Infection Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of C Difficile Infection Drug, Product Type & Application
Table 12. Global Key Manufacturers of C Difficile Infection Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global C Difficile Infection Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in C Difficile Infection Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global C Difficile Infection Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global C Difficile Infection Drug Sales by Region (2020-2025) & (K MT)
Table 18. Global C Difficile Infection Drug Sales Market Share by Region (2020-2025)
Table 19. Global C Difficile Infection Drug Sales by Region (2026-2031) & (K MT)
Table 20. Global C Difficile Infection Drug Sales Market Share by Region (2026-2031)
Table 21. Global C Difficile Infection Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global C Difficile Infection Drug Revenue Market Share by Region (2020-2025)
Table 23. Global C Difficile Infection Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global C Difficile Infection Drug Revenue Market Share by Region (2026-2031)
Table 25. North America C Difficile Infection Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America C Difficile Infection Drug Sales by Country (2020-2025) & (K MT)
Table 27. North America C Difficile Infection Drug Sales by Country (2026-2031) & (K MT)
Table 28. North America C Difficile Infection Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America C Difficile Infection Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe C Difficile Infection Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe C Difficile Infection Drug Sales by Country (2020-2025) & (K MT)
Table 32. Europe C Difficile Infection Drug Sales by Country (2026-2031) & (K MT)
Table 33. Europe C Difficile Infection Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe C Difficile Infection Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific C Difficile Infection Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific C Difficile Infection Drug Sales by Region (2020-2025) & (K MT)
Table 37. Asia Pacific C Difficile Infection Drug Sales by Region (2026-2031) & (K MT)
Table 38. Asia Pacific C Difficile Infection Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific C Difficile Infection Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America C Difficile Infection Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America C Difficile Infection Drug Sales by Country (2020-2025) & (K MT)
Table 42. Latin America C Difficile Infection Drug Sales by Country (2026-2031) & (K MT)
Table 43. Latin America C Difficile Infection Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America C Difficile Infection Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa C Difficile Infection Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa C Difficile Infection Drug Sales by Country (2020-2025) & (K MT)
Table 47. Middle East and Africa C Difficile Infection Drug Sales by Country (2026-2031) & (K MT)
Table 48. Middle East and Africa C Difficile Infection Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa C Difficile Infection Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global C Difficile Infection Drug Sales (K MT) by Type (2020-2025)
Table 51. Global C Difficile Infection Drug Sales (K MT) by Type (2026-2031)
Table 52. Global C Difficile Infection Drug Sales Market Share by Type (2020-2025)
Table 53. Global C Difficile Infection Drug Sales Market Share by Type (2026-2031)
Table 54. Global C Difficile Infection Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global C Difficile Infection Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global C Difficile Infection Drug Revenue Market Share by Type (2020-2025)
Table 57. Global C Difficile Infection Drug Revenue Market Share by Type (2026-2031)
Table 58. Global C Difficile Infection Drug Price (USD/MT) by Type (2020-2025)
Table 59. Global C Difficile Infection Drug Price (USD/MT) by Type (2026-2031)
Table 60. Global C Difficile Infection Drug Sales (K MT) by Application (2020-2025)
Table 61. Global C Difficile Infection Drug Sales (K MT) by Application (2026-2031)
Table 62. Global C Difficile Infection Drug Sales Market Share by Application (2020-2025)
Table 63. Global C Difficile Infection Drug Sales Market Share by Application (2026-2031)
Table 64. Global C Difficile Infection Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global C Difficile Infection Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global C Difficile Infection Drug Revenue Market Share by Application (2020-2025)
Table 67. Global C Difficile Infection Drug Revenue Market Share by Application (2026-2031)
Table 68. Global C Difficile Infection Drug Price (USD/MT) by Application (2020-2025)
Table 69. Global C Difficile Infection Drug Price (USD/MT) by Application (2026-2031)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck C Difficile Infection Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 73. Merck C Difficile Infection Drug Product
Table 74. Merck Recent Developments/Updates
Table 75. Astellas Company Information
Table 76. Astellas Description and Business Overview
Table 77. Astellas C Difficile Infection Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 78. Astellas C Difficile Infection Drug Product
Table 79. Astellas Recent Developments/Updates
Table 80. Eli Lilly Company Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly C Difficile Infection Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 83. Eli Lilly C Difficile Infection Drug Product
Table 84. Eli Lilly Recent Developments/Updates
Table 85. ANI Pharmaceutical Company Information
Table 86. ANI Pharmaceutical Description and Business Overview
Table 87. ANI Pharmaceutical C Difficile Infection Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. ANI Pharmaceutical C Difficile Infection Drug Product
Table 89. ANI Pharmaceutical Recent Developments/Updates
Table 90. Flynn Pharma Company Information
Table 91. Flynn Pharma Description and Business Overview
Table 92. Flynn Pharma C Difficile Infection Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 93. Flynn Pharma C Difficile Infection Drug Product
Table 94. Flynn Pharma Recent Developments/Updates
Table 95. Aspen Pharmacare Company Information
Table 96. Aspen Pharmacare Description and Business Overview
Table 97. Aspen Pharmacare C Difficile Infection Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 98. Aspen Pharmacare C Difficile Infection Drug Product
Table 99. Aspen Pharmacare Recent Developments/Updates
Table 100. Akorn Company Information
Table 101. Akorn Description and Business Overview
Table 102. Akorn C Difficile Infection Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 103. Akorn C Difficile Infection Drug Product
Table 104. Akorn Recent Developments/Updates
Table 105. Merus labs Company Information
Table 106. Merus labs Description and Business Overview
Table 107. Merus labs C Difficile Infection Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 108. Merus labs C Difficile Infection Drug Product
Table 109. Merus labs Recent Developments/Updates
Table 110. Pfizer Company Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer C Difficile Infection Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 113. Pfizer C Difficile Infection Drug Product
Table 114. Pfizer Recent Developments/Updates
Table 115. AstraZeneca Company Information
Table 116. AstraZeneca Description and Business Overview
Table 117. AstraZeneca C Difficile Infection Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 118. AstraZeneca C Difficile Infection Drug Product
Table 119. AstraZeneca Recent Developments/Updates
Table 120. Strides Company Information
Table 121. Strides Description and Business Overview
Table 122. Strides C Difficile Infection Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 123. Strides C Difficile Infection Drug Product
Table 124. Strides Recent Developments/Updates
Table 125. Sanofi Company Information
Table 126. Sanofi Description and Business Overview
Table 127. Sanofi C Difficile Infection Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 128. Sanofi C Difficile Infection Drug Product
Table 129. Sanofi Recent Developments/Updates
Table 130. Fresenius Company Information
Table 131. Fresenius Description and Business Overview
Table 132. Fresenius C Difficile Infection Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 133. Fresenius C Difficile Infection Drug Product
Table 134. Fresenius Recent Developments/Updates
Table 135. Xellia Company Information
Table 136. Xellia Description and Business Overview
Table 137. Xellia C Difficile Infection Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 138. Xellia C Difficile Infection Drug Product
Table 139. Xellia Recent Developments/Updates
Table 140. Zhejiang Medicine Company Information
Table 141. Zhejiang Medicine Description and Business Overview
Table 142. Zhejiang Medicine C Difficile Infection Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 143. Zhejiang Medicine C Difficile Infection Drug Product
Table 144. Zhejiang Medicine Recent Developments/Updates
Table 145. Lupin Company Information
Table 146. Lupin Description and Business Overview
Table 147. Lupin C Difficile Infection Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 148. Lupin C Difficile Infection Drug Product
Table 149. Lupin Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. C Difficile Infection Drug Distributors List
Table 153. C Difficile Infection Drug Customers List
Table 154. C Difficile Infection Drug Market Trends
Table 155. C Difficile Infection Drug Market Drivers
Table 156. C Difficile Infection Drug Market Challenges
Table 157. C Difficile Infection Drug Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of C Difficile Infection Drug
Figure 2. Global C Difficile Infection Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global C Difficile Infection Drug Market Share by Type: 2024 & 2031
Figure 4. Metronidazole Product Picture
Figure 5. Vancomycin Product Picture
Figure 6. Fidaxomycin Product Picture
Figure 7. Others Product Picture
Figure 8. Global C Difficile Infection Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global C Difficile Infection Drug Market Share by Application: 2024 & 2031
Figure 10. Pre-treatment
Figure 11. Mid-term treatment
Figure 12. Others
Figure 13. Global C Difficile Infection Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global C Difficile Infection Drug Market Size (2020-2031) & (US$ Million)
Figure 15. Global C Difficile Infection Drug Sales (2020-2031) & (K MT)
Figure 16. Global C Difficile Infection Drug Average Price (USD/MT) & (2020-2031)
Figure 17. C Difficile Infection Drug Report Years Considered
Figure 18. C Difficile Infection Drug Sales Share by Manufacturers in 2024
Figure 19. Global C Difficile Infection Drug Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest C Difficile Infection Drug Players: Market Share by Revenue in C Difficile Infection Drug in 2024
Figure 21. C Difficile Infection Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global C Difficile Infection Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America C Difficile Infection Drug Sales Market Share by Country (2020-2031)
Figure 24. North America C Difficile Infection Drug Revenue Market Share by Country (2020-2031)
Figure 25. U.S. C Difficile Infection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada C Difficile Infection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe C Difficile Infection Drug Sales Market Share by Country (2020-2031)
Figure 28. Europe C Difficile Infection Drug Revenue Market Share by Country (2020-2031)
Figure 29. Germany C Difficile Infection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France C Difficile Infection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. C Difficile Infection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy C Difficile Infection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia C Difficile Infection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific C Difficile Infection Drug Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific C Difficile Infection Drug Revenue Market Share by Region (2020-2031)
Figure 36. China C Difficile Infection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan C Difficile Infection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea C Difficile Infection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India C Difficile Infection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia C Difficile Infection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Taiwan C Difficile Infection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia C Difficile Infection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand C Difficile Infection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia C Difficile Infection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Philippines C Difficile Infection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America C Difficile Infection Drug Sales Market Share by Country (2020-2031)
Figure 47. Latin America C Difficile Infection Drug Revenue Market Share by Country (2020-2031)
Figure 48. Mexico C Difficile Infection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil C Difficile Infection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina C Difficile Infection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa C Difficile Infection Drug Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa C Difficile Infection Drug Revenue Market Share by Country (2020-2031)
Figure 53. Turkey C Difficile Infection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia C Difficile Infection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. UAE C Difficile Infection Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of C Difficile Infection Drug by Type (2020-2031)
Figure 57. Global Revenue Market Share of C Difficile Infection Drug by Type (2020-2031)
Figure 58. Global C Difficile Infection Drug Price (USD/MT) by Type (2020-2031)
Figure 59. Global Sales Market Share of C Difficile Infection Drug by Application (2020-2031)
Figure 60. Global Revenue Market Share of C Difficile Infection Drug by Application (2020-2031)
Figure 61. Global C Difficile Infection Drug Price (USD/MT) by Application (2020-2031)
Figure 62. C Difficile Infection Drug Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
